Back to Search
SCOTT WELLMANN, MD
MD
Cardiovascular Disease Physician
NPI: 1912970716Individual
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
4068(AK)
Pediatrics Physician
Pediatrics
Code: 208000000X
4068(AK)
Research & Publications (19)
Hypoxia upregulates the histone demethylase JMJD1A via HIF-1.
PMID 18538129·Biochem Biophys Res Commun·2008
7-preclinical
Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death.
PMID 17763999·J Neurooncol·2008
8-other
Erythropoietin and ischemic conditioning--why two good things may be bad.
PMID 17537001·Acta Paediatr·2007
7-preclinical
The thalidomide analogue, CC-4047, induces apoptosis signaling and growth arrest in childhood acute lymphoblastic leukemia cells in vitro and in vivo.
PMID 17000689·Clin Cancer Res·2006
7-preclinical
The Wilms tumor suppressor Wt1 promotes cell adhesion through transcriptional activation of the alpha4integrin gene.
PMID 16920711·J Biol Chem·2006
7-preclinical
Brief communication: stability and catalytic activity of novel circular DNAzymes.
PMID 16898416·Nucleosides Nucleotides Nucleic Acids·2006
8-other
Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
PMID 16030311·J Natl Cancer Inst·2005
8-other
FLT3 mutations in childhood acute lymphoblastic leukemia at first relapse.
PMID 15674414·Leukemia·2005
8-other
Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomas.
PMID 15668788·Acta Neuropathol·2005
4-observational
CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels.
PMID 15516494·Am J Physiol Lung Cell Mol Physiol·2005
7-preclinical
Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma.
PMID 15354209·Br J Cancer·2004
3-trial
Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism.
PMID 15075239·J Cell Sci·2004
7-preclinical
Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF.
PMID 15014526·Leukemia·2004
8-other
Comparison between TaqMan and LightCycler technologies for quantification of minimal residual disease by using immunoglobulin and T-cell receptor genes consensus probes.
PMID 14562127·Leukemia·2003
4-observational
Oxygen-regulated expression of the Wilms' tumor suppressor Wt1 involves hypoxia-inducible factor-1 (HIF-1).
PMID 12738801·FASEB J·2003
7-preclinical
Deletion analysis of p16(INKa) and p15(INKb) in relapsed childhood acute lymphoblastic leukemia.
PMID 12036898·Blood·2002
8-other
Prognostic value of p16(INK4a) gene deletions in pediatric acute lymphoblastic leukemia.
PMID 11405214·Blood·2001
8-other
Specific reverse transcription-PCR quantification of vascular endothelial growth factor (VEGF) splice variants by LightCycler technology.
PMID 11274014·Clin Chem·2001
8-other
Acute hypoxia and reoxygenation impairs exhaled nitric oxide release and pulmonary mechanics.
PMID 10788814·J Thorac Cardiovasc Surg·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3260 PROVIDENCE DR, SUITE 532
ANCHORAGE, AK 99508 - Phone
- (907) 565-2242
Quick Facts
- NPI
- 1912970716
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile